Niagen Bioscience's total assets for Q3 2025 were $98.14M, an increase of 7.23% from the previous quarter. NAGE total liabilities were $27.46M for the fiscal quarter, a 0.49% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.